SPC388
Lungnahnettlu-fjölsykru samtengt bóluefni (15-gilt, aðsogið) sem er svifblanda af hjúpuðum fjölsykrum úr S. Pneumoniae sermigerðum 1, 2, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F og 33F sem er samtengt við CRM197 burðarprótín
Status:
VeittApplication date:
10.6.2022Application published:
15.7.2022Grant published:
15.3.2025
Max expiry date:
18.4.2032Medicine name:
VaxneuvanceMedicine for children:
No
Timeline
Today
10.6.2022Application
15.7.2022Publication
15.3.2025Registration
18.4.2032Expires
Marketing license
IS authorization number:
EU/1/21/1591/001-006Date:
31.12.2021
Foreign authorization number:
EU/1/21/1591Date:
13.12.2021
Owner
Name:
Wyeth LLCAddress:
66 Hudson Boulevard East, New York, NY 10001-2192 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2676679
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 01.01.1